Surgery, Gastroenterology and Oncology
Vol. 19, No. 1-2, January October 2014
MRI IN SPINAL BONE MARROW REPLACEMENT DISORDERS
Ioana G. Lupescu
REVIEW, January October 2014
Article DOI: 10.21614/jtmr-19-2-17
Objectives. The paper aims are: to present and illustrate the MRI aspects of the normal and pathological bone marrow involving the spine, focusing on MR techniques and interpretation in a precise clinico-biological context of each patient. Material and methods. The cases included in this study were explored using a 1.5 MRI system in T1-weighted, T2 FSE, STIR, FSE T2 Fat Sat sequences, in sagittal and or coronal plane. Sections made in the axial plane in T2 wi, were centered at the level of the lesion(s). In case of primitive or secondary tumoral lesions we have performed T1-weighted SE sequences Fat Sat pre- and post-iv. injection of Gd-BOPTA in multiple planes. In particular cases, we have used T1-weighted sections with a TE in and out of phase. Imaging features. Normally, the bone marrow shows intermediate signal both on T1- ,T2 - , Stir- weighted images in comparison to paravertebral muscle. Pathological aspects include: diffuse and focal tumor infiltration (leukemia, lymphoma, multiple myeloma, metastasis), that must be differentiate from hyperplasia (reconversion) of the red marrow, bone marrow depletion, supportive tissue pathology (primary and secondary myelofibrosis, Gaucher disease). Conclusions. MRI is the only imaging method that allows the analysis of the bone marrow. Knowledge of normal signal in different MRI sequences in correlation with the age and the clinico-biological context of the patient is essential for a correct interpretation and detection of different types of diseases involving bone marrow of the spine. In patients with a diffuse T1 hyposignal of the spinal bone marrow the differential diagnosis includes three main entities: conversion, myeloproliferative lesions and pathology of the support structures.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 5853


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.